Expert Perspectives & Insights into CAR T-cell Therapy in Relapsed / Refractory Acute Lymphoblastic Leukemia - Episode 8
Treatment Considerations and Patient Selection for CAR T-cell Therapy in R/R ALL
The panel evaluates key patient characteristics and clinical factors influencing the decision to recommend CAR T-cell therapy as a treatment option in relapsed or refractory acute lymphoblastic leukemia.
Video content above is prompted by the following:
- What patient factors do you take into consideration when deciding whether a patient may be a good candidate for using CAR T-cell therapy?
- What patient characteristics and/or disease attributes would you favor treatment with Brexu-cel?
- What percentage of your patients are eligible for treatment with Brexu-cel?